Literature DB >> 15855780

Reversible visual deficit and Corpus callosum lesions due to metronidazole toxicity.

Jan L De Bleecker1, Bart P Leroy, Veronique I Meire.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15855780     DOI: 10.1159/000085506

Source DB:  PubMed          Journal:  Eur Neurol        ISSN: 0014-3022            Impact factor:   1.710


× No keyword cloud information.
  7 in total

1.  MR imaging of metronidazole-induced encephalopathy: lesion distribution and diffusion-weighted imaging findings.

Authors:  E Kim; D G Na; E Y Kim; J H Kim; K R Son; K H Chang
Journal:  AJNR Am J Neuroradiol       Date:  2007-09-20       Impact factor: 3.825

2.  Metronidazole-induced encephalopathy: a systematic review.

Authors:  Caspar Godthaab Sørensen; William Kristian Karlsson; Faisal Mohammad Amin; Mette Lindelof
Journal:  J Neurol       Date:  2018-12-07       Impact factor: 4.849

3.  Metronidazole induced encephalopathy in a patient with brain abscess.

Authors:  Yoochang Bahn; Eunyoung Kim; Chongoon Park; Hyung-Chun Park
Journal:  J Korean Neurosurg Soc       Date:  2010-09-30

Review 4.  Clinical and Neuroradiological Spectrum of Metronidazole Induced Encephalopathy: Our Experience and the Review of Literature.

Authors:  Ujjawal Roy; Ajay Panwar; Alak Pandit; Susanta Kumar Das; Bhushan Joshi
Journal:  J Clin Diagn Res       Date:  2016-06-01

5.  Isolated involvement of corpus callosum in metronidazole-induced encephalopathy with concomitant peripheral neuropathy: A case report.

Authors:  Qing Peng; Qian You; Jing Zhang; Shui Liu
Journal:  Medicine (Baltimore)       Date:  2020-05       Impact factor: 1.889

6.  Atypical metronidazole-induced encephalopathy in anaerobic brain abscess.

Authors:  Han Jin Jang; Sook Young Sim; Jong Yun Lee; Ji Hwan Bang
Journal:  J Korean Neurosurg Soc       Date:  2012-09-30

7.  Metronidazole-induced encephalopathy in a patient with pyogenic spondylitis: a case report.

Authors:  Kazutaka Mizuta; Motoki Sonohata; Osamu Nozaki; Tomoki Kobatake; Daisuke Nakayama; Tadatsugu Morimoto; Masaaki Mawatari
Journal:  BMC Musculoskelet Disord       Date:  2018-09-18       Impact factor: 2.362

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.